Navigation Links
Serono Symposia International Foundation (SSIF) Launches a New Web Site Dedicated to Medical Education on Phenylketonuria (PKU)
Date:8/31/2010

Serono Symposia International Foundation (SSIF) Launches a New Web Site Dedicated to Medical... -- ROME, August 31, 2010 /PRNewswire/ --


Advanced Search Search

  
Close
  1. Send a release
  2. Member sign in
  3. Become a member
  4. For journalists
  5. Global sites
PR Newswire: news distribution, targeting and monitoring
  1. Products & Services
  2. Knowledge Center
  3. Browse News Releases
  4. Contact PR Newswire
Web Site, Biotechnology, Health Care & Hospitals, Medical Pharmaceuticals, New Products & Services Click to view news release full screen  

Serono Symposia International Foundation (SSIF) Launches a New Web Site Dedicated to Medical Education on Phenylketonuria (PKU)

 

Download image

ROME, August 31, 2010 /PRNewswire/ --

- A New Tool is Targeted to Specialists in PKU, Offering an Advanced Educational Pathway Consisting of CME Accredited e-Learning Modules

PKU specialists around the world can now count on a brand-new, authoritative website entirely dedicated to this rare genetic disorder, which affects one out of every 10,000 to 20,000 live births worldwide.

(Photo: http://www.newscom.com/cgi-bin/prnh/20100629/397361 )

The web site will be launched during the 2010 SSIEM Annual Symposium (Society for the Study of the Inborn Errors of Metabolism) held in Istanbul from August the 31st to September the 3rd. This meeting provides a prestigious platform from which scientists and physicians will have the opportunity to share their opinions and experiences on the vast array of metabolic problems.

The PKU Academy website (http://www.pkuacademy.org) meets the full range of educational needs of healthcare professionals dealing with PKU, and provides many educational tools including CME-accredited online courses, a glossary, a bibliography and FAQs. The website has two main areas: the PKU Academy section, which provides the users with simple educational tools enabling them to acquire a basic and up-to-date knowledge of the disease; and the PKU Masters, an area addressed to specialists offering a more advanced educational pathway consisting of CME-accredited e-learning modules.

"Continuous medical education is a must," said Nenad Blau, Professor of Clinical Biochemistry at the Division of Clinical Chemistry and Biochemistry, University Children's Hospital of Zurich, and a member of the PKU Editorial Board of the new PKU web site, "and PKU specialists around the world can now count on the most up-to-date source of medical knowledge by top worldwide experts on each aspect of the disease including genetics, diagnosis, and treatment."

"This kind of authoritative knowledge," added Professor Blau, "will be provided through user-friendly educational tools and e-learning modules, which will enable the users to refer to this new web site in a self-tailored way according to personal and professional needs, time and skills."

The user-friendly educational tools within the Academy area of the web site include a dedicated PKU Glossary - an evolving tool and core reference of key terms that will provide rapid updates and explanations of all terms related to the disease and mentioned in the web site - and a Frequently Asked Question section providing the most authoritative answers to even the most common questions asked about the disorder.

Healthcare professionals seeking a more in-depth understanding of PKU can also undertake the online courses addressing topics from pathophysiology and diagnosis, to management of PKU. The professionals completing the online courses are entitled to CME credits.

The Secretary of the Board of Directors Mr Jean-Daniel Baki reported that the Board is proud of this new step and accomplishment, which reflects the long term commitment of Serono Symposia International Foundation to cover the medical educational needs of a wide range of diseases, including so-called "rare" diseases.

Healthcare professionals already working in PKU will find the e-learning modules of the PKU Masters area of the new web site an invaluable way of deepening and broadening their understanding of this difficult condition.

Any further and additional information will be provided at the SSIF Booth 14 in the SSIEM Annual Symposium. Specialists can register on-site, completely free of charge.

http://www.pkuacademy.org. and http://www.pkuacademy.org/masters

Serono Symposia International Foundation is a non-profit organization based in Geneva (Switzerland). It was founded to disseminate the most innovative achievements and potential developments of medical and scientific research through conferences, training courses, online courses, and publications. In particular, it provides Continuing Medical Education for doctors and healthcare professionals by organizing high-level scientific programs. Over the past four decades Serono Symposia International Foundation has organized more than 1500 international scientific congresses and published more than 500 proceedings with the most important international publishers.

Contact Details: Media contact Serono Symposia International Foundation Salita San Nicola da Tolentino 1/b Rome, Italy Ph.: +39-06-420-413 E-mail: info@seronosymposia.org
'/>"/>

SOURCE Serono Symposia International Foundation
Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. EMD Serono Named as a Top Employer by Science Magazine
2. Merck Serono Named as a Top Employer by Science Magazine
3. Michael J. Fox Foundation Awards $2 Million Grant From EMD Serono to Research Projects on Cognitive Deficits in Parkinsons Disease
4. EMD Serono Launches Landmark Patient Registry for Egg Freezing
5. Merck Serono Launches Strategic Venture Capital Fund
6. Oncothyreon announces temporary suspension of Stimuvax clinical trials by Merck Serono
7. Inaugural Kavli Prize ceremony and symposia: Sept. 8-11 (Oslo, Norway)
8. Nobel Laureates to Speak at Keystone Symposia RNA Silencing Conference
9. CME Enterprise Named to Manage All Industry-Supported Symposia at 2010 APA Annual Meeting
10. China Yingxia International, Inc. Announces Conference Call to Discuss Second Quarter 2008 Results
11. Yongye Biotechnology International Retains CCG Investor Relations
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/24/2016)... ... June 24, 2016 , ... While the majority of commercial spectrophotometers and fluorometers ... the 6000i models are higher end machines that use the more unconventional z-dimension of ... beam from the bottom of the cuvette holder. , FireflySci has developed several ...
(Date:6/23/2016)... 2016 /PRNewswire/ - FACIT has announced the creation ... biotechnology company, Propellon Therapeutics Inc. ("Propellon" or "the ... a portfolio of first-in-class WDR5 inhibitors for the ... WDR5 represent an exciting class of therapies, possessing ... for cancer patients. Substantial advances have been achieved ...
(Date:6/23/2016)... 2016  The Biodesign Challenge (BDC), a university competition ... harness living systems and biotechnology, announced its winning teams ... New York City . The ... projects at MoMA,s Celeste Bartos Theater during the daylong ... senior curator of architecture and design, and Suzanne ...
(Date:6/23/2016)... Apellis Pharmaceuticals, Inc. today announced positive ... its complement C3 inhibitor, APL-2. The trials were ... studies designed to assess the safety, tolerability, pharmacokinetics ... healthy adult volunteers. Forty subjects were ... dose (ranging from 45 to 1,440mg) or repeated ...
Breaking Biology Technology:
(Date:3/31/2016)... R.I. , March 31, 2016  Genomics firm ... of founding CEO, Barrett Bready , M.D., who ... members of the original technical leadership team, including Chief ... President of Product Development, Steve Nurnberg and Vice President ... returned to the company. Dr. Bready served ...
(Date:3/23/2016)... March 23, 2016 ... Sicherheit Gesichts- und Stimmerkennung mit Passwörtern ... (NASDAQ: MESG ), ein führender Anbieter ... Unternehmen mit SpeechPro zusammenarbeitet, um erstmals dessen ... wird die Möglichkeit angeboten, im Rahmen mobiler ...
(Date:3/22/2016)... Ontario , PROVO and ... Newborn Screening Ontario (NSO), which operates the ... for molecular testing, and Tute Genomics and UNIConnect, ... management technology respectively, today announced the launch of a ... next-generation sequencing (NGS) testing panel. NSO ...
Breaking Biology News(10 mins):